Grape King Bio (TPE:1707) Institutional Ownership: 8.45% (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1707 Grape King Bio Ltd TPE:1707
78 GF Score
Price NT$89.60
GF Value NT$138.74
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Grape King Bio Institutional Ownership?

Grape King Bio TPE:1707 -0.99% 78 Institutional Ownership is 8.45% as of Aug. 05, 2026. GuruFocus rates TPE:1707 with a GF Score™ of 78/100 and a GF Value™ of NT$138.74 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Grape King Bio's institutional ownership is 8.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Grape King Bio's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Grape King Bio's Float Percentage Of Total Shares Outstanding is 0.00%.

Grape King Bio Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Institutional Ownership Chart

Grape King Bio Historical Data

The historical data trend for Grape King Bio can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 8.64 8.09 8.33 8.36 8.36 8.44 8.26 8.24 8.17 8.45
TPE:1707
78GF Score
Grape King Bio Ltd TPE:1707
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 8.45% mean?
Grape King Bio (TPE:1707) has a Institutional Ownership of 8.45% as of Aug. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Grape King Bio and its competitors.
Is Grape King Bio's Institutional Ownership too high?
Grape King Bio's current Institutional Ownership is 8.45%. Overall, Grape King Bio has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Institutional Ownership compare to ZTS?
Grape King Bio's Institutional Ownership of 8.45% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Grape King Bio and its competitors. Grape King Bio's current Institutional Ownership is 8.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$138.74, compared to a current price of NT$89.60 — trading 35.4% below its estimated fair value. The current Institutional Ownership is 8.45%. Grape King Bio's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Institutional Ownership is 8.45% as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$89.60 is trading 35.4% below its estimated GF Value™ of NT$138.74. GuruFocus considers Grape King Bio to be Significantly Undervalued.

Key valuation signals for TPE:1707:

  • Institutional Ownership: 8.45%
  • GF Value™: NT$138.74 vs. price of NT$89.60 (35.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
78GF Score

Get the complete analysis for TPE:1707

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$89.60
Price
NT$138.74
GF Value